A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity.
about
The ubiquitin system: a critical regulator of innate immunity and pathogen-host interactionsDeubiquitinases: Novel Therapeutic Targets in Immune Surveillance?Linear ubiquitination in immunityThe intersection of cell death and inflammasome activationNF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases.Hypomorphic A20 expression confers susceptibility to psoriasis.The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosisCaspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome SignalingAnti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens.A20 overexpression alleviates pristine-induced lupus nephritis by inhibiting the NF-κB and NLRP3 inflammasome activation in macrophages of mice.Discrete spatial organization of TGFβ receptors couples receptor multimerization and signaling to cellular tensionLoss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory diseaseNovel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behçet's diseasePosttranscriptional control of NLRP3 inflammasome activation in colonic macrophages.Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis.The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3.Post-translational regulation of inflammasomes.Caspase-8: not so silently deadly.The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitination.Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.Regulation of inflammasomes by ubiquitination.Post-translational control of RIPK3 and MLKL mediated necroptotic cell death.Autoinflammatory diseases: update on classification diagnosis and management.Lessons from characterization and treatment of the autoinflammatory syndromes.Mechanisms of RIPK3-induced inflammation.The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology.Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.Inflammasomes and intestinal inflammation.The many ways tissue phagocytes respond to dying cells.Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune Recognition.Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling.Sterile signals generate weaker and delayed macrophage NLRP3 inflammasome responses relative to microbial signals.The Atypical Ubiquitin E2 Conjugase UBE2L3 Is an Indirect Caspase-1 Target and Controls IL-1β Secretion by Inflammasomes.K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
P2860
Q28067104-40798D83-21D9-438B-8763-1F40B95DCA8CQ28069021-F73D1596-3DFA-4272-BC67-898DEAD15740Q28082899-586B474C-96BC-40AE-A3C9-7DBCFF704350Q28274739-D46975B7-09CD-4724-9747-E4C2D1067F17Q33576114-E088FCE2-4A63-4316-9EDC-B79A2645D4C7Q33848572-FDB1DAA6-D33E-4A7B-B6DB-E04D5F605EC4Q35630131-96354087-6914-490C-A0CA-5F8B29CD106AQ35781701-91EB2A34-7DE5-4C89-9709-531907C9BA6BQ35953090-D5120AAA-1403-4043-B3DB-6C466BA6C6F2Q36006797-5C30089C-8C9D-4C99-8CE4-9114A65C1AF1Q36411522-95335BE1-20C6-449A-8CD4-6DD3EB6C1A08Q36505979-76DACC86-2842-458C-9E71-1A7256B4782AQ36649404-ADBDFB77-905E-492E-9E8D-14CC3C309C93Q36882843-BAB9F0BE-0D8C-4057-A1EE-7F8BCA5EA546Q36957892-FB0E71B2-2D40-41A1-AA64-48FAF70494E9Q37065065-8B5F4472-1DE8-4160-BFB0-64089AC2537BQ37500927-E102B297-5359-4B98-BE6A-F575CF01577FQ37559665-54B69CAB-7DA2-41A8-A033-B81E21951813Q37625431-D0710258-1405-4EF2-A4A2-47D646A69785Q38530646-5DF48993-899A-4C4D-B3AB-3340F7B81930Q38746358-82730AF9-51B1-4687-9BEA-F4284E2C6B24Q38803966-05E36B0D-4548-4B09-B28C-B75642D3D86AQ38829463-FC42CFFE-8267-4076-B097-44A16A2133E6Q38959075-B1FB454E-4DDA-41B2-A701-38389B8A4FBEQ39025839-56CCB03F-AF63-4237-8216-B47D9B063AE9Q39038663-700301EF-21C0-4945-9117-3896620BD112Q39077160-650E1363-14D4-4C93-908B-DBD481B654ABQ39086011-A5C92E7A-6FE2-4228-934C-B170B24DDACCQ39207486-8EC1C813-7DBD-468D-8030-9DE1B20C623EQ39210955-D04C4C76-C464-4316-8327-0DD58AE67D4FQ39237282-CAAC0F2B-3A22-47D5-B84C-195D7314C91FQ39277496-D7282C68-2397-4E34-9A62-C3A62CB4EC24Q39374120-7EF2BB4A-9CA1-4D87-B6D4-2E4EF19FB11BQ39376982-59F27E36-8E1A-4458-8A47-9A065223F825Q39436645-C5914D50-06BF-4741-BD64-E6BE9093959BQ39443996-6661851C-13C4-498A-94EC-4628DCE65DFAQ39574742-008177C2-DCF4-4FCC-B4D6-D0FB7B2D6A8FQ39904158-03521D1E-64C7-4B99-B15C-4AC9AA5FEA03Q40070954-A29E7B76-CE3B-4215-8501-CCD974AC614AQ41636978-A7C306CC-0A46-4999-A877-3E2CD8A14429
P2860
A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A20 restricts ubiquitination o ...... s NLRP3 inflammasome activity.
@ast
A20 restricts ubiquitination o ...... s NLRP3 inflammasome activity.
@en
A20 restricts ubiquitination o ...... s NLRP3 inflammasome activity.
@nl
type
label
A20 restricts ubiquitination o ...... s NLRP3 inflammasome activity.
@ast
A20 restricts ubiquitination o ...... s NLRP3 inflammasome activity.
@en
A20 restricts ubiquitination o ...... s NLRP3 inflammasome activity.
@nl
prefLabel
A20 restricts ubiquitination o ...... s NLRP3 inflammasome activity.
@ast
A20 restricts ubiquitination o ...... s NLRP3 inflammasome activity.
@en
A20 restricts ubiquitination o ...... s NLRP3 inflammasome activity.
@nl
P2093
P2860
P921
P1433
P1476
A20 restricts ubiquitination o ...... s NLRP3 inflammasome activity.
@en
P2093
Bao H Duong
Barbara A Malynn
Juan A Oses-Prieto
Michio Onizawa
Rommel Advincula
P2860
P356
10.1016/J.IMMUNI.2014.12.031
P407
P577
2015-01-01T00:00:00Z